Ketamin, Enthält Benzethoniumchlorid G.L. (Ketamine)

Ketamine blocks the NMDA receptor, a key excitatory neurotransmitter pathway in the central nervous system. This antagonism disrupts normal synaptic transmission, producing dissociative anesthesia, analgesia, and sedation while typically preserving airway reflexes.

The dose of ketamine is individualized by the prescribing clinician based on the patient’s age, weight, clinical condition, and route of administration. Healthcare professionals determine the appropriate amount and infusion rate.

Safety data for ketamine in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Ketamine differs from many inhalational or opioid‑based anesthetics by providing dissociative anesthesia without significant respiratory depression. It also offers analgesic properties and maintains cardiovascular stability, making it useful in trauma or emergency settings where other agents may cause hypotension.

Ketamin, Enthält Benzethoniumchlorid G.L. should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain potency.

Ketamine is administered by a qualified healthcare professional via intramuscular injection or intravenous infusion. The route, rate, and total dose are determined by the clinical situation and the prescriber’s judgment.

Serious risks include respiratory depression, severe hypertension or tachycardia, cardiac arrhythmias, emergence reactions such as hallucinations, and rare neurotoxic effects with high cumulative dosing. Continuous monitoring is essential during administration.

Ketamine is contraindicated in patients with known hypersensitivity to the drug, uncontrolled hypertension, severe cardiovascular disease, and those with a history of psychosis where emergence phenomena could be hazardous. Clinical judgment should guide use in all cases.